Quantcast

PositiveID’s iglucose System Addresses Patient, Healthcare and Insurance Provider Needs to Help Improve Outcomes and Decrease Costs to the Healthcare System

October 26, 2011

PositiveID Corporation (OTCBB: PSID) the parent company of the iglucose̢Ң system is bringing the future technology of diabeties management to consumers now has created a comprehensive video presentation to show the many beneffits of iglucose systems.

Delray Beach, Florida USA (PRWEB) October 26, 2011

PositiveID Corporation, (OTCBB: PSID) the developer of the iglucose̢Ң system, is bringing the future technology of diabetes management to consumers now, and has created a comprehensive video presentation to show the many benefits of the iglucose system. The video is available here: iglucose РSimplifying Diabetes Management http://www.positiveidcorp.com/products_iglucose.html

The powerful and easy-to-use iglucose mobile health system is designed to work with existing popular glucose meters already in the market and will be integrated to work in concert with a major breakthrough product in development and getting closer to coming to market from PositiveID â“ the companyâs non-invasive (no pricks or blood required) breath-based glucose tester called Easy Checkâ“¢. This revolutionary product will simply allow the user to blow into the device to get glucose readings. These readings could, of course, be transmitted with the iglucose system for the desired persons to read and monitor. The breath-based glucose meter is ready for pre-trial testing and is rapidly heading towards US Food and Drug Administration submission and entry into the marketplace.

iglucose has been submitted to the FDA and is pending clearance.

PositiveID Corporation (OTCBB: PSID) develops unique medical devices and molecular diagnostic systems focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MicroFluidic Systems or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID Corporation was formed on November 10, 2009 through the merger of VeriChip Corporation and Steel Vault Corporation.

PositiveID operates in two main divisions: HealthID and SecurityID. The HealthID segment develops unique medical devices, focused primarily on diabetes management, and rapid medical testing applications. Its SecurityID segment develops airborne bio-threat detection systems.

For more information or an interview with PositiveID Corporation (OTCBB: PSID) please email or call for scheduling:

Allison Tomek

Sr. VP, Investor Relations & Corporate Communications

PositiveID Corporation (OTCBB: PSID.)

T: 561-805-8044

F: 561-805-8001

atomek(at)positiveidcorp(dot)com

PositiveID Corporation (OTCBB: PSID)    Tools and Technology for a Better Life

http://positiveidcorp.com http://iglucose.com

Copyright © 2011 All rights reserved.

PR: http://www.MassMedia77.com

Safe Harbor Statement

Statements about PositiveIDâs future expectations, including the likelihood that PositiveID is bringing the future technology of diabetes management to consumers now; the likelihood that the iglucose mobile health system is designed to work with existing popular glucose meters already in the market and will be integrated to work in concert with a major breakthrough product in development and getting closer to coming to market from PositiveID – the companyâs non-invasive breath-based glucose tester called Easy Check; the likelihood that Easy Check will simply allow the user to blow into the device to get glucose readings; the likelihood that these readings could be transmitted with the iglucose system for the desired persons to read and monitor; the likelihood that the breath-based glucose meter is ready for pre-trial testing and is rapidly heading towards FDA submission and entry into the marketplace; and all other statements in this release other than historical facts are âœforward-looking statementsâ within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveIDâs actual results could differ materially from expected results. These risks and uncertainties include PositiveIDâs ability to successfully develop and commercialize its iglucose system and Easy Check device; as well as certain other risks. Additional information about these and other factors that could affect the Companyâs business is set forth in the Companyâs various filings with the Securities and Exchange Commission, including those set forth in the Companyâs 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, and August 15, 2011, under the caption âœRisk Factors.â The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Analystsâ Compensation: Mass Media 77, Inc. who in part or in whole may be responsible for the preparation of this report may receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues, which include revenues from, among other business units, Institutional Equities and Investment Banking and restricted stock.

Information has been obtained from sources believed to be reliable but Mass Media 77, Inc or its affiliates and/or subsidiaries (collectively Mass Media 77, Inc.) do not warrant its completeness or accuracy. Opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. The recipient of this report must make its own independent decisions regarding any securities or financial instruments mentioned herein. Periodic updates may be provided on companies/industries based on company specific developments or announcements, market conditions or any other publicly available information. Additional information may be available upon request.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011_iglucose/10_Video/prweb8910634.htm


Source: prweb



comments powered by Disqus